These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22925945)

  • 21. [Recommendations in the empiric anti-infective agents of intra-abdominal infection].
    Guirao X; Arias J; Badía JM; García-Rodríguez JA; Mensa J; Alvarez-Lerma F; Borges M; Barberán J; Maseda E; Salavert M; Llinares P; Gobernado M; García Rey C
    Rev Esp Quimioter; 2009 Sep; 22(3):151-72. PubMed ID: 19662549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bacteria fight back.
    Taubes G
    Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract]   [Full Text] [Related]  

  • 23. [Infectiousness in general surgery. The bacteria found and the use of antibiotics].
    Chevalley F; Tschantz P
    Rev Med Suisse Romande; 1986 Nov; 106(11):979-83. PubMed ID: 3809849
    [No Abstract]   [Full Text] [Related]  

  • 24. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multidrug resistance and antibiotic treatment].
    Gayet S
    Soins; 1997 Nov; (620):11-4. PubMed ID: 9479198
    [No Abstract]   [Full Text] [Related]  

  • 26. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
    McDonald LC
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing multidrug-resistant organisms in home care and hospice: surveillance, prevention, and control.
    McGoldrick M; Rhinehart E
    Home Healthc Nurse; 2007 Oct; 25(9):580-6; quiz 587-8. PubMed ID: 18049254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiresistant Gram-negative infections: a global perspective.
    Ho J; Tambyah PA; Paterson DL
    Curr Opin Infect Dis; 2010 Dec; 23(6):546-53. PubMed ID: 20802331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic resistance: measures urgently needed].
    Kluytmans J; Vandenbroucke-Grauls C; van der Meer JW
    Ned Tijdschr Geneeskd; 2010; 154():A2261. PubMed ID: 20858324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of the emergence of bacterial resistance in the hospital environment.
    Hosein IK; Hill DW; Jenkins LE; Magee JT
    J Appl Microbiol; 2002; 92 Suppl():90S-7S. PubMed ID: 12000618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The issue of antimicrobial resistance in human medicine.
    Beović B
    Int J Food Microbiol; 2006 Dec; 112(3):280-7. PubMed ID: 16815582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spectrum of microbial colonisation and resistance of a surgical ICU in a systematic comparison of the 10-year time period 1996-2005 using routine microbiological testing].
    Arndt S; Lauf H; Weiss G; Lodes U; Mroczkowski P; Schulz HU; Lippert H; König W; Meyer F
    Zentralbl Chir; 2011 Apr; 136(2):152-8. PubMed ID: 21425047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring antimicrobial drug resistance in hospital microorganisms. Definition of problems and methods.
    Møller JK
    Dan Med Bull; 1990 Jun; 37(3):263-74. PubMed ID: 2192838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction: the challenge of multiresistance.
    Livermore DM
    Int J Antimicrob Agents; 2007 May; 29 Suppl 3():S1-7. PubMed ID: 17659208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antibacterial chemotherapy in the surgical intensive care unit].
    Peters G
    Klin Wochenschr; 1991; 69 Suppl 26():47-52. PubMed ID: 1813730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in antibacterial therapy against emerging bacterial pathogens.
    Pournaras S; Iosifidis E; Roilides E
    Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals.
    Fridkin SK; Hill HA; Volkova NV; Edwards JR; Lawton RM; Gaynes RP; McGowan JE;
    Emerg Infect Dis; 2002 Jul; 8(7):697-701. PubMed ID: 12095437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What should and should not be covered in intraabdominal infection].
    Guirao X
    Enferm Infecc Microbiol Clin; 2010 Sep; 28 Suppl 2():32-41. PubMed ID: 21130928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.